|
|
The effect of calcium dobesilate on the formation of atherosclerotic plaques and its mechanism |
WANG Ying, LI Cai, ZHU Feng, JIN Xiaoping |
Department of Neurology, Taizhou Hospital, Taizhou 317000, China |
|
Cite this article: |
WANG Ying,LI Cai,ZHU Feng, et al. The effect of calcium dobesilate on the formation of atherosclerotic plaques and its mechanism[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2020, 50(5): 387-390.
|
|
Abstract Objective: To discuss the effect of calcium dobesilate on the formation of atherosclerotic plaques in rabbits and its mechanism. Methods: Atherosclerotic plaque model was set up by liquid nitrogen frostbite in 24 health male New Zealand rabbits. The rabbits were randomly divided as the model group (n=12) and the treatment group (n=12). The model group was given high-fat diet for 8 weeks, while the treatment group was given high-fat diet and calcium dobesilate (0.15 mg·g-1·d-1) for 8 weeks. Serum endothelin-1 (ET-1), nitric oxide (NO) and vascular endothelial growth factor (VEGF) were measured by ELISA before the experiment and after 8 weeks of treatment. After 8 weeks, the animals were killed, the right common carotid artery was removed, and the pathomorphological changes were observed by light microscope and electron microscope. The expression of matrix metalloproteinase 9 (MMP-9) and plasminogen activator inhibitor-1 (PAI-1) were detected by immunohistochemistry. Results: After 8 weeks, the vascular intima in the model group showed typical atherosclerotic plaque lesions, while the vascular intima in the treatment group showed slight atherosclerotic plaque lesions. The expression of PAI-1 and MMP-9 protein was observed locally in the carotid arteries of both groups, but the expression level in the treatment group was significantly lower than that in the model group (P<0.05). The expression of ET-1 was significantly decreased. The expression of NO and VEGF was significantly increased in both groups, but the decrease in ET-1 in the treatment group was greater than that in the model group, the increase in NO and VEGF was greater than that in the model group, with significant difference (P<0.05). Conclusion: Calcium dobesilate can improve endothelial dysfunction by reducing the expression of PAI-1 and MMP-9 proteins in local vascular walls, reducing the ET-1 content in blood circulation and increasing the levels of NO and VEGF, which play the role of anti-atherosclerotic plaque formation.
|
Received: 01 September 2019
|
|
|
|
|
[1] LIBBY P, RIDKER P M, MASERI A. Inflammation and atherosclerosis[J]. Circulation, 2001, 105(9): 1135-1143.
[2] 李娟, 孙源博, 王德平, 等. 羟苯磺酸钙胶囊治疗单纯型糖
尿病视网膜病变疗效观察[J]. 中国医院用药评价与分析, 2015, 15(4): 469-471.
[3] FANG S M, ZHANG Q H, JIANG Z X. Developing a novel rabbit model of atherosclerotic plaque rupture and thrombosis by cold-induced endothelial injury[J]. J Biomed Sci, 2009, 16: 39.
[4] TUZOV A, ZAITSEV K, NACHMAN R, et al. Sudden death due to eosinophilic arteritis of a major coronary artery [J]. Harefuah, 2012, 151(3): 159-161, 189.
[5] VAN-ASSCHE T, HUYGELEN V, CRABTREE M J, et al. Gene therapy targeting inflammation in atherosclerosis[J]. Curr Pharm Des, 2011, 17(37): 4210-4223.
[6] WILLIAMS J K, SUKHOVA G K, HERRINGTON D M, et al. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys[J]. J Am Coll Cardiol, 1998, 31(3): 684-691.
[7] 梁慧敏, 李玉珠, 郑永丽, 等. miR-132在动脉粥样硬化中 的表达及对缺氧诱导的血管内皮细胞增殖凋亡的影响[J]. 中国老年学杂志, 2019, 39(9): 2228-2231.
[8] 杨雁华, 汤建民, 来桂棵, 等. 正五聚蛋白3对血管紧张素 II刺激后血管内皮细胞凋亡及血管活性物质分泌的影响 [J]. 中国老年学杂志, 2019, 39(9): 2193-2197.
[9] 曹绍华, 王云, 井雷, 等. 肺内皮功能障碍与肺动脉高压病 变研究进展[J]. 中国老年学杂志, 2012,32(2): 433-436.
[10] 陈冠鹏, 包浔娜, 何星球, 等. 冠心病患者血清胆红素水 平与血管内皮功能的相关性[J]. 海南医学, 2017, 28(16): 2590-2592.
[11] 张鑫利, 王敏, 罗光华, 等. 高密度脂蛋白-内皮型一氧化 氮合酶信号通路在心血管系统中的作用及其影响因素的 研究进展[J]. 中国病理生理杂志, 2017, 33(12): 2293-2298.
[12] 鞠文浩, 刘金波, 赵红薇, 等. 高盐饮食对健康人和高血压 患者血浆血管内皮生长因子C水平的影响及其与血压的 相关性研究[J]. 中国循环杂志, 2018, 33(4): 346-350.
[13] 安建中, 洪蕾. 动脉粥样硬化成因的分子机制研究进展[J]. 中国心血管病研究, 2018, 16(9): 778-781.
[14] AIMSTRONG E J, MORROW D A, SABATINE M S. Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of plateletaetivation[J]. Circulation, 2006, 113(9): 382-385.
[15] 张凤梅, 王德宝, 吴鹤, 等. 高尿酸血症患者血浆t-PA、 PAI-1水平变化及与颈动脉粥样硬化的关系[J]. 山东医药, 2014, 54(27): 74-75.
[16] ZHANG X, LIU W, WU S, et al. Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis[J]. Sci China Life Sci, 2015, 58(1): 101-107.
[17] 梁文生. 羟苯磺酸钙治疗老年冠心病心绞痛的临床观察 [J]. 中外健康文摘, 2010, 7(24): 98-99.
[18] HAIDET J, CIFARELLI V, GENG X, et al. C-peptide:a new molecule with anti-inflammatory properties[J]. Diabetes CPeptide, 2012, 2012(10): 111-127. |
[1] |
. [J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2022, 52(8): 0-. |
|
|
|
|